What is Global Angiogenesis Assay Market?
The Global Angiogenesis Assay Market is a specialized sector that focuses on the process of angiogenesis, which is the formation of new blood vessels from pre-existing ones. This process is crucial in many biological events such as growth and development, wound healing, and the formation of granulation tissue. However, it is also a fundamental step in the transition of tumors from a benign state to a malignant one. The market is dedicated to providing assays, or tests, that can measure angiogenesis in a controlled environment. These assays are used in various fields, including medical research, drug development, and cancer treatment. The market is driven by the increasing prevalence of diseases that require angiogenesis for diagnosis and treatment, such as cancer and cardiovascular diseases. The market also benefits from advancements in technology that allow for more accurate and efficient assays.
In Vitro Assay Kit, In Vivo Assay Kit in the Global Angiogenesis Assay Market:
The Global Angiogenesis Assay Market is divided into two main product types: In Vitro Assay Kit and In Vivo Assay Kit. The In Vitro Assay Kit is designed to measure angiogenesis in a controlled laboratory environment. These kits typically include all the necessary reagents and materials to perform the assay, including endothelial cells, growth factors, and matrices. On the other hand, the In Vivo Assay Kit is designed to measure angiogenesis in a living organism. These kits include reagents and materials that can be injected into the organism to induce and measure angiogenesis. Both types of kits are crucial in the market, as they cater to different research needs and applications. The choice between the two depends on the specific requirements of the research or experiment, such as the need for a controlled environment or the ability to observe angiogenesis in a living organism.
Academic Institution, Biotech Companies in the Global Angiogenesis Assay Market:
The Global Angiogenesis Assay Market is widely used in various sectors, including Academic Institutions and Biotech Companies. Academic Institutions utilize these assays for research and educational purposes. They are used in studies related to angiogenesis, such as understanding the process itself, identifying factors that influence it, and developing methods to control it. These assays are also used in teaching, where students can learn about angiogenesis and gain hands-on experience in performing the assays. On the other hand, Biotech Companies use these assays in their research and development activities. They are used in the development of new drugs and treatments that target angiogenesis. These companies also use the assays to test the efficacy and safety of their products. The assays provide valuable data that can guide the companies in their development process, ensuring that their products are effective and safe for use.
Global Angiogenesis Assay Market Outlook:
Looking at the market outlook, the Global Angiogenesis Assay Market was valued at a substantial US$ 18 million in 2023. It is projected to experience significant growth, reaching an estimated value of US$ 31 million by 2030. This represents a compound annual growth rate (CAGR) of 7.8% during the forecast period from 2024 to 2030. The market is dominated by the top five manufacturers, who collectively hold a market share of over 65%. In terms of product types, the In Vitro Assay Kit is the leading segment, accounting for over 95% of the market. This dominance is likely due to the kit's versatility and convenience, making it a popular choice among researchers and institutions.
| Report Metric | Details |
| Report Name | Angiogenesis Assay Market |
| Accounted market size in 2023 | US$ 18 million |
| Forecasted market size in 2030 | US$ 31 million |
| CAGR | 7.8% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Abcam, Bio-Techne, Thermo Fisher Scientific, Cell Biolabs, Inc., BioVision, Inc, PromoCell GmbH, Merck KGaA, Kollodis BioSciences, Sartorius (Essen BioScience), Creative Bioarray |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
